Literature DB >> 1313229

Aldosterone antagonists destabilize the mineralocorticosteroid receptor.

B Couette1, M Lombes, E E Baulieu, M E Rafestin-Oblin.   

Abstract

To elucidate the mechanism of action of aldosterone antagonists, we studied the interaction of spironolactone with the chick mineralocorticosteroid receptor (MR). Intestinal cytosol contains specific spironolactone-binding sites (Kd approximately 3 nM; max. no. of binding sites approximately 100 fmol/mg of protein) that have been identified as MRs by competition experiments with steroid ligands and with the monoclonal anti-idiotypic antibody H10E that interacts with aldosterone-binding domain of the MR. Binding studies indicate that aldosterone and spironolactone bind to the MR through a common site that encompasses the epitope recognized by H10E. At 4 degrees C, spironolactone dissociates much more rapidly from the cytosol 8-9 S form of MR (t1/2 38 min) than does aldosterone (t1/2 3240 min). A high dissociation rate was also observed for progesterone, a natural aldosterone antagonist (t1/2 84 min). The covalent linkage of the 90 kDa heat shock protein (hsp90) to the ligand-binding subunit of MR with dimethyl pimelimidate did not notably modify the rate of dissociation of spironolactone from the receptor (t1/2 96 min), excluding the possibility that the rapid dissociation rate of the antagonist was related to hsp90 release. The effects of aldosterone and the two anti-mineralocorticosteroids on the 8-9 S heterooligomeric structure of the MR differed strikingly. Using low-salt density-gradient centrifugation analysis, aldosterone-labelled receptors were recovered as 8-9S complexes, whereas 4 S entities were detected after spironolactone and progesterone binding. This indicated that, under the experimental conditions used, aldosterone antagonists facilitate hsp90 release and thus do not stabilize the non-DNA-binding 8-9S form of MR. We propose that the combination of rapid dissociation of the ligand and a weakened hsp90-receptor interaction is involved in the anti-mineralococorticosteroid activity of aldosterone antagonists.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313229      PMCID: PMC1130843          DOI: 10.1042/bj2820697

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Identification of hormone-interacting amino acid residues within the steroid-binding domain of the glucocorticoid receptor in relation to other steroid hormone receptors.

Authors:  J Carlstedt-Duke; P E Strömstedt; B Persson; E Cederlund; J A Gustafsson; H Jörnvall
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

2.  Location of the second steroid-binding site on the glucocorticoid receptor.

Authors:  F Svec; V Teubner; D Tate
Journal:  Endocrinology       Date:  1989-12       Impact factor: 4.736

3.  A region in the steroid binding domain determines formation of the non-DNA-binding, 9 S glucocorticoid receptor complex.

Authors:  W B Pratt; D J Jolly; D V Pratt; S M Hollenberg; V Giguere; F M Cadepond; G Schweizer-Groyer; M G Catelli; R M Evans; E E Baulieu
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

4.  Improvement in glucocorticoid receptor binding affinity concomitant to shift from antagonist to agonist activity in a series of 17 beta-carboxamide derivatives of dexamethasone.

Authors:  P Lefebvre; P Formstecher; G G Rousseau; P Lustenberger; M Dautrevaux
Journal:  J Steroid Biochem       Date:  1989-10       Impact factor: 4.292

5.  Affinity of corticosteroids for mineralocorticoid and glucocorticoid receptors of the rabbit kidney: effect of steroid substitution.

Authors:  M E Rafestin-Oblin; M Lombes; P Lustenberger; P Blanchardie; A Michaud; G Cornu; M Claire
Journal:  J Steroid Biochem       Date:  1986-10       Impact factor: 4.292

6.  Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro.

Authors:  A Groyer; G Schweizer-Groyer; F Cadepond; M Mariller; E E Baulieu
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Identification of cysteine-644 as the covalent site of attachment of dexamethasone 21-mesylate to murine glucocorticoid receptors in WEHI-7 cells.

Authors:  L I Smith; J E Bodwell; D B Mendel; T Ciardelli; W G North; A Munck
Journal:  Biochemistry       Date:  1988-05-17       Impact factor: 3.162

8.  Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor.

Authors:  E H Bresnick; F C Dalman; E R Sanchez; W B Pratt
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

9.  Internal image properties of a monoclonal auto-anti-idiotypic antibody and its binding to aldosterone receptors.

Authors:  M Lombes; I S Edelman; B F Erlanger
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

10.  The common 90-kd protein component of non-transformed '8S' steroid receptors is a heat-shock protein.

Authors:  M G Catelli; N Binart; I Jung-Testas; J M Renoir; E E Baulieu; J R Feramisco; W J Welch
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

View more
  8 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Corticosteroid receptor antagonists: a current perspective.

Authors:  W Sutanto; E R de Kloet
Journal:  Pharm World Sci       Date:  1995-03-24

3.  Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist binding as revealed by a new monoclonal antibody.

Authors:  S Jalaguier; B Lupo; G Hugon; M E Rafestin-Oblin; G Auzou
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

5.  Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements.

Authors:  M Lombès; N Binart; M E Oblin; V Joulin; E E Baulieu
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

6.  Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists.

Authors:  M Lombès; N Binart; F Delahaye; E E Baulieu; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

7.  Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.

Authors:  B Couette; J Fagart; S Jalaguier; M Lombes; A Souque; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

8.  The infralimbic mineralocorticoid blockage prevents the stress-induced impairment of aversive memory extinction in rats.

Authors:  Kairo Alan Albernaz-Mariano; Carolina Demarchi Munhoz
Journal:  Transl Psychiatry       Date:  2022-08-24       Impact factor: 7.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.